报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2024-09-30 | 24.97% | 7.49% | -0.54% | 39/51 | 35.76% | 南华生物 | 68.03% | 行业排名> |
2024-06-30 | 25.1% | 6.38% | 4.41% | 40/51 | 35.89% | 百诚医药 | 68.75% | 行业排名> |
2024-03-31 | 24.04% | -1.39% | 7.41% | 40/51 | 35.75% | 百诚医药 | 68.19% | 行业排名> |
2023-12-31 | 22.39% | 2.95% | -3.64% | 44/51 | 38.13% | 药康生物 | 67.61% | 行业排名> |
2023-09-30 | 23.23% | 2% | -1.56% | 45/51 | 39.87% | 药康生物 | 69.14% | 行业排名> |
2023-06-30 | 23.6% | 2.24% | -3.22% | 45/51 | 39.77% | 药康生物 | 68.49% | 行业排名> |
2023-03-31 | 24.38% | 2% | 12.14% | 44/51 | 38.93% | 药康生物 | 69.3% | 行业排名> |
2022-12-31 | 21.74% | -9.93% | -5.79% | 47/51 | 40.1% | 药康生物 | 71.38% | 行业排名> |
2022-06-30 | 23.08% | -9.34% | -4.4% | 45/51 | 39.96% | 药康生物 | 73.27% | 行业排名> |
2021-12-31 | 24.14% | 0.73% | -5.17% | 46/51 | 41.94% | 药康生物 | 75.32% | 行业排名> |
2021-06-30 | 25.46% | 7.59% | 6.22% | 43/51 | 42.6% | 药康生物 | 76.7% | 行业排名> |
2020-12-31 | 23.97% | -2.61% | 1.29% | 46/51 | 38.51% | 药康生物 | 74.33% | 行业排名> |
2020-06-30 | 23.66% | 2% | -3.85% | 35/51 | 39.28% | 南华生物 | 84.53% | 行业排名> |
2019-12-31 | 24.61% | 5.61% | 5.61% | 45/51 | 42.94% | 南华生物 | 83.19% | 行业排名> |
2018-12-31 | 23.31% | -2.18% | -2.18% | 44/51 | 42.09% | 南华生物 | 83.9% | 行业排名> |
2017-12-31 | 23.83% | 2% | 2% | 39/51 | 40.94% | 成都先导 | 79.36% | 行业排名> |